Home ›
Trademark Categories ›
Advertising & Business ›
2018 ›
EN ›
ENTYVIOCONNECT HOME
Trademark search for:
ENTYVIOCONNECT HOME
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-10-01 — Application filed
2018-10-04 — Application filed
2018-10-09 — Application filed
2019-01-11 — Assigned to examiner
2019-01-14 — Final disposition recorded
2019-01-14 — Final disposition recorded
2019-01-14 — Final disposition recorded
2019-07-09 — Office action issued
2019-07-09 — Correspondence received in law office
2019-07-10 — Teas/email correspondence entered
2019-07-10 — Approved for pub - principal register
2019-07-21 — Assigned to lie
2019-08-07 — Notification of notice of publication e-mailed
2019-08-27 — Published for opposition
2019-08-27 — Official gazette publication confirmation e-mailed
2019-08-29 — Teas change of correspondence received
2019-09-23 — Teas revoke/app/change addr of atty/dom rep received
2019-09-23 — Attorney/dom.rep.revoked and/or appointed
2019-10-22 — Noa e-mailed - sou required from applicant
2020-04-08 — Sou teas extension received
2020-04-08 — Sou extension 1 filed
2020-04-08 — Sou extension 1 granted
2020-04-10 — Notice of approval of extension request e-mailed
2020-07-01 — Teas change of owner address received
2020-07-01 — Teas revoke/app/change addr of atty/dom rep received
2020-07-01 — Attorney/dom.rep.revoked and/or appointed
2020-07-01 — Teas change of correspondence received
2020-07-01 — Applicant/correspondence changes (non-responsive) entered
2020-11-23 — Application abandoned
2020-11-23 — Application abandoned
2020-11-23 — Final status recorded
Owner Information
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Correspondent
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
